Enoxaparin Ledraxen® is a high-quality, sterile anticoagulant solution manufactured by Venopharm. It contains Enoxaparin Sodium, a Low Molecular Weight Heparin (LMWH) that inhibits clotting factors to prevent the formation of harmful blood clots. This presentation (6.000 IE/0.6 ml) is a versatile dosage form suitable for both subcutaneous and intravenous administration. It is supplied in a box of 10 ready-to-use pre-filled syringes, each equipped with an advanced safety system to ensure maximum protection for healthcare professionals.

Key Features and Benefits

• Dual Route of Administration: This formulation is designed for flexible use, indicated for both subcutaneous injection (standard anticoagulation therapy) and intravenous use (for specific procedures).
• Specialized Extracorporeal Application: Specifically indicated for use in extracorporeal circuits, such as the dialysis circuit, to prevent clotting during hemodialysis sessions.
• Precise, Ready-to-Use Dosage: Each pre-filled syringe contains exactly 6.000 IE (60 mg) of Enoxaparin Sodium in a 0.6 ml solution. This eliminates the need for manual drawing, saving time and ensuring dosing accuracy.
• Integrated Safety System: The syringes come with a built-in safety mechanism that activates after injection, shielding the needle to significantly reduce the risk of accidental needle-stick injuries.
• High Pharmaceutical Standard: Manufactured by Venopharm, ensuring strict adherence to quality and safety standards.

Indications and Usage
Enoxaparin Ledraven® is indicated for:

• Prophylaxis and Treatment of Thromboembolic Disorders: Used subcutaneously for the prevention of deep vein thrombosis (DVT) and pulmonary embolism.
• Extracorporeal Circulation: Administered to prevent clot formation in the dialysis circuit during hemodialysis.
• Acute Coronary Syndromes: Used as part of the management protocol for certain cardiac conditions (as directed by a physician).

Important Safety Information
This is a potent prescription medication intended for hospital or specialized clinical use only. It must be administered under the supervision of a qualified healthcare professional. Patients should be monitored for signs of bleeding or bruising.

• Contraindications: Do not use in patients with active major bleeding, history of heparin-induced thrombocytopenia (HIT), or hypersensitivity to Enoxaparin.
• Storage: Store below 25°C. Do not freeze. Keep out of reach of children.

Product Specifications

• Active Ingredient: Enoxaparin Sodium
• Strength: 6.000 IE Anti-Xa (equivalent to 60 mg)
• Volume: 0.6 ml
• Route: Subcutaneous or Intravenous (Extracorporeal)
• Format: 10 Pre-filled syringes with Safety System
• Manufacturer: Venopharm

Disclaimer: This description is for informational purposes only and does not constitute medical advice. Always refer to the official product leaflet and consult a healthcare professional for complete prescribing information.